血管新生緑内障
WordNet
- an eye disease that damages the optic nerve and impairs vision (sometimes progressing to blindness); "contrary to popular belief, glaucoma is not always caused by elevated intraocular pressure"
PrepTutorEJDIC
- あおそこひ,緑内障(視力が減退する眼病)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Preservative Exposure and Surgical Outcomes in Glaucoma Patients: The PESO Study.
- Boimer C, Birt CM.Author information *Faculty of Medicine, University of Toronto †Department of Ophthalmology and Vision Sciences, University of Toronto and Sunnybrook Health Sciences Centre, Toronto, ON, Canada.AbstractPURPOSE: To study the impact of benzalkonium chloride (BAK) exposure from eye drops on subsequent time to trabeculectomy failure.
- Journal of glaucoma.J Glaucoma.2013 Dec;22(9):730-5. doi: 10.1097/IJG.0b013e31825af67d.
- PURPOSE: To study the impact of benzalkonium chloride (BAK) exposure from eye drops on subsequent time to trabeculectomy failure.PATIENTS AND METHODS: Retrospective chart review of 128 glaucoma patients who had undergone a trabeculectomy between 2004 and 2006. The number and type of ophthalmic drops
- PMID 23524856
- Efficacy of intravitreal bevacizumab with panretinal photocoagulation followed by ahmed valve implantation in neovascular glaucoma.
- Mahdy RA, Nada WM, Fawzy KM, Alnashar HY, Almosalamy SM.Author information Department of Ophthalmology, Faculty of Medicine, Zagazig University, Zagazig, Sharkeya, Egypt.AbstractPURPOSE: To establish the efficacy and safety of intravitreal bevacizumab (Avastin) with panretinal photocoagulation (PRP) followed by Ahmed valve implantation in the treatment of neovascular glaucoma (NVG).
- Journal of glaucoma.J Glaucoma.2013 Dec;22(9):768-72. doi: 10.1097/IJG.0b013e318259aec4.
- PURPOSE: To establish the efficacy and safety of intravitreal bevacizumab (Avastin) with panretinal photocoagulation (PRP) followed by Ahmed valve implantation in the treatment of neovascular glaucoma (NVG).METHOD: This prospective randomized study included 40 eyes of 40 patients with refractory NVG
- PMID 22790513
- The ocular renin-angiotensin system: A therapeutic target for the treatment of ocular disease.
- Giese MJ, Speth RC.Author information Bascom Palmer Eye Institute, Palm Beach Gardens, FL 33418, United States. Electronic address: mgiese1960@gmail.com.AbstractThe renin-angiotensin system (RAS) is most well-known for its role in regulation and dysregulation of blood pressure as well as fluid and electrolyte homeostasis. Due to its ability to cause cardiovascular disease, the RAS is the target of a multitude of drugs that antagonize its pathophysiological effects. While the "classical" RAS is a systemic hormonal system, there is an increasing awareness of the existence and functional significance of local RASs in a number of organs, e.g., liver, kidney, heart, lungs, reproductive organs, adipose tissue and adrenal. The eye is one of these organs where a compelling body of evidence has demonstrated the presence of a local RAS. Individual components of the RAS have been shown to be present in many structures of the eye and their potential functional significance in ocular disease states is described. Because the eye is one of the most important and complex organs in the body, this review also discusses the implications of dysregulation of the systemic RAS on the pathogenesis of ocular diseases and how pharmacological manipulation of the RAS might lead to novel or adjunctive therapies for ocular disease states.
- Pharmacology & therapeutics.Pharmacol Ther.2013 Nov 25. pii: S0163-7258(13)00220-9. doi: 10.1016/j.pharmthera.2013.11.002. [Epub ahead of print]
- The renin-angiotensin system (RAS) is most well-known for its role in regulation and dysregulation of blood pressure as well as fluid and electrolyte homeostasis. Due to its ability to cause cardiovascular disease, the RAS is the target of a multitude of drugs that antagonize its pathophysiological
- PMID 24287313
Japanese Journal
- 血管新生緑内障に対する強膜開窓毛様体光凝固術(cyclophotocoagulation ab externa,臼井法)の治療成績
- A CLINICOPATHOLOGICAL STUDY OF YAG LASER TRANSSCLERAL CYCLOPHOTOCOAGULATION
- Yoshii Toshiaki,Nawa Yosmaki,Fukuhara Jun,Hara Yosmaki
- Journal of Nara Medical Association 55(1), 37-42, 2004-02-29
- … We conducted a clinicopathological study of an eye of a 58-year-old Japanese man who had undergone a transscleral YAG cyclophotocoagulation for rubeotic glaucoma. …
- NAID 120004972851
- 富永 美果,廣辻 徳彦,杉山 哲也,中島 正之,池田 恒彦
- 眼科手術 = Journal of ophthalmic surgery 15(2), 267-270, 2002-04-30
- NAID 10010057587
Related Links
- Chronic glaucoma: the causes, what happens, the treatment, investigations, in Good Hope Eye Department, avastin anti-vegf, cyclodioe, retinal laser ... Retinal veins drain the blood out of the eye (). They may become damaged by ...
- Neovascular glaucoma (NVG) is classified as a secondary glaucoma. First documented in 1871, historically, it has been referred to as hemorrhagic glaucoma, thrombotic glaucoma, congestive glaucoma, rubeotic ...
★リンクテーブル★
[★]
- 英
- neovascular glaucoma, rubeotic glaucoma
- 関
- 出血性緑内障、緑内障